These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9154264)

  • 1. Anxiety disorders, comorbid substance abuse, and benzodiazepine discontinuation: implications for treatment.
    Barlow DH
    NIDA Res Monogr; 1997; 172():33-51. PubMed ID: 9154264
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzodiazepines and the treatment of anxiety disorders in patients with comorbid alcohol and/or drug abuse.
    Sher L
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170-1. PubMed ID: 18354817
    [No Abstract]   [Full Text] [Related]  

  • 3. Comorbidity of panic disorder and substance use disorders.
    Mueller TI; Swift RM
    R I Med; 1992 May; 75(5):277-80. PubMed ID: 1606327
    [No Abstract]   [Full Text] [Related]  

  • 4. Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Stinson FS; Grant BF; Dawson DA; Ruan WJ; Huang B; Saha T
    Drug Alcohol Depend; 2005 Oct; 80(1):105-16. PubMed ID: 16157233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences. A study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway.
    Bakken K; Landheim AS; Vaglum P
    Drug Alcohol Depend; 2005 Dec; 80(3):321-8. PubMed ID: 15964156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of comorbid major depression and substance use disorders on alcohol and drug treatment: results of a national survey.
    Grant BF
    NIDA Res Monogr; 1997; 172():4-15. PubMed ID: 9154262
    [No Abstract]   [Full Text] [Related]  

  • 7. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need.
    Otto MW; Bruce SE; Deckersbach T
    J Clin Psychiatry; 2005; 66 Suppl 2():34-8. PubMed ID: 15762818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.
    Goldstein BI; Levitt AJ
    Bipolar Disord; 2008 Feb; 10(1):67-78. PubMed ID: 18199243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety disorders and the use and abuse of drugs.
    Roth SM
    J Clin Psychiatry; 1989 Nov; 50 Suppl():30-5. PubMed ID: 2681172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and addiction: a clinical perspective on comorbidity.
    DuPont RL
    Bull Menninger Clin; 1995; 59(2 Suppl A):A53-72. PubMed ID: 7795572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity in older adults with bipolar disorder.
    Sajatovic M; Blow FC; Ignacio RV
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):582-7. PubMed ID: 16783798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
    Schatzberg AF; Weiss RD; Brady KT; Culpepper L
    CNS Spectr; 2008 Apr; 13(4 Suppl 6):3. PubMed ID: 18408653
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding and treating comorbid anxiety disorders in substance users: review and future directions.
    Wolitzky-Taylor K; Operskalski JT; Ries R; Craske MG; Roy-Byrne P
    J Addict Med; 2011 Dec; 5(4):233-47. PubMed ID: 22042216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and substance use: layers of complexity.
    Castle DJ
    Expert Rev Neurother; 2008 Mar; 8(3):493-501. PubMed ID: 18345977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spousal concordance for substance use and anxiety disorders.
    Low N; Cui L; Merikangas KR
    J Psychiatr Res; 2007 Dec; 41(11):942-51. PubMed ID: 17204289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.